Yüklüyor......
Immunotherapy advances for glioblastoma
Survival for patients with glioblastoma, the most common high-grade primary CNS tumor, remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy, targeting dysregulated cell signaling pathways, and blocking angiogenesis. Exciting, durable clinical benefits have...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4201077/ https://ncbi.nlm.nih.gov/pubmed/25190673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou212 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|